Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2021

 

Upgrades

  • Seaport Global upgraded the previous rating for Public Service Enterprise Group Inc PEG from Neutral to Buy. Public Service Enterprise earned $1.28 in the first quarter, compared to $1.03 in the year-ago quarter. The stock has a 52-week-high of $64.30 and a 52-week-low of $46.70. At the end of the last trading period, Public Service Enterprise closed at $63.02.
  • Morgan Stanley upgraded the previous rating for MorphoSys AG MOR from Equal-Weight to Overweight. In the first quarter, MorphoSys showed an EPS of $1.53, compared to $6.74 from the year-ago quarter. The current stock performance of MorphoSys shows a 52-week-high of $35.73 and a 52-week-low of $19.75. Moreover, at the end of the last trading period, the closing price was at $21.59.
  • HSBC upgraded the previous rating for Nutrien Ltd NTR from Hold to Buy. In the first quarter, Nutrien earned $0.29. The stock has a 52-week-high of $62.37 and a 52-week-low of $30.56. At the end of the last trading period, Nutrien closed at $59.96.
  • For Shoals Technologies Group Inc SHLS, Credit Suisse upgraded the previous rating of Neutral to Outperform. Interestingly, in the first quarter, Shoals Technologies Gr's EPS was $0.05. At the moment, the stock has a 52-week-high of $44.04 and a 52-week-low of $20.94. Shoals Technologies Gr closed at $24.39 at the end of the last trading period.
  • Morgan Stanley upgraded the previous rating for Ollie's Bargain Outlet Holdings Inc OLLI from Underweight to Equal-Weight. Ollie's Bargain Outlet earned $0.97 in the fourth quarter, compared to $0.74 in the year-ago quarter. At the moment, the stock has a 52-week-high of $123.52 and a 52-week-low of $75.75. Ollie's Bargain Outlet closed at $76.35 at the end of the last trading period.
  • According to Bernstein, the prior rating for Beyond Meat Inc BYND was changed from Underperform to Outperform. In the first quarter, Beyond Meat showed an EPS of $0.42, compared to $0.03 from the year-ago quarter. The current stock performance of Beyond Meat shows a 52-week-high of $221.00 and a 52-week-low of $99.86. Moreover, at the end of the last trading period, the closing price was at $106.59.

See all analyst ratings upgrades.

 

Downgrades

  • According to Keybanc, the prior rating for Cimarex Energy Co XEC was changed from Overweight to Sector Weight. Cimarex Energy earned $1.98 in the first quarter, compared to $0.58 in the year-ago quarter. The current stock performance of Cimarex Energy shows a 52-week-high of $74.92 and a 52-week-low of $22.39. Moreover, at the end of the last trading period, the closing price was at $71.19.
  • Morgan Stanley downgraded the previous rating for Melco Resorts and Entertainment Ltd MLCO from Overweight to Equal-Weight. For the first quarter, Melco Resorts and Enter had an EPS of $0.44, compared to year-ago quarter EPS of $0.76. The current stock performance of Melco Resorts and Enter shows a 52-week-high of $23.65 and a 52-week-low of $14.18. Moreover, at the end of the last trading period, the closing price was at $17.34.
  • According to HSBC, the prior rating for The Mosaic Co MOS was changed from Buy to Hold. In the first quarter, Mosaic showed an EPS of $0.57, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $38.23 and a 52-week-low of $11.41. At the end of the last trading period, Mosaic closed at $35.46.
  • B of A Securities downgraded the previous rating for Dollar General Corp DG from Neutral to Underperform. For the fourth quarter, Dollar General had an EPS of $2.62, compared to year-ago quarter EPS of $2.10. The stock has a 52-week-high of $225.25 and a 52-week-low of $173.50. At the end of the last trading period, Dollar General closed at $205.04.
  • According to Baird, the prior rating for Proofpoint Inc PFPT was changed from Outperform to Neutral. For the first quarter, Proofpoint had an EPS of $0.49, compared to year-ago quarter EPS of $0.38. The stock has a 52-week-high of $174.25 and a 52-week-low of $91.60. At the end of the last trading period, Proofpoint closed at $171.16.
  • According to Jefferies, the prior rating for Campbell Soup Co CPB was changed from Buy to Hold. In the second quarter, Campbell Soup showed an EPS of $0.84, compared to $0.72 from the year-ago quarter. At the moment, the stock has a 52-week-high of $54.08 and a 52-week-low of $44.53. Campbell Soup closed at $48.87 at the end of the last trading period.

See all analyst ratings downgrades.

 

Initiations

  • UBS initiated coverage on FTC Solar Inc FTCI with a Buy rating. The price target for FTC Solar is set to $13.00. The stock has a 52-week-high of $15.46 and a 52-week-low of $7.79. At the end of the last trading period, FTC Solar closed at $8.62.
  • JP Morgan initiated coverage on Privia Health Group Inc PRVA with an Overweight rating. The price target for Privia Health Group is set to $40.00. The current stock performance of Privia Health Group shows a 52-week-high of $39.58 and a 52-week-low of $27.15. Moreover, at the end of the last trading period, the closing price was at $32.81.
  • With a Equal-Weight rating, Morgan Stanley initiated coverage on Endeavor Group Holdings Inc EDR. The price target seems to have been set at $30.00 for Endeavor Group Holdings. For the first quarter, Endeavor Group Holdings had an EPS of $0.07, compared to year-ago quarter EPS of $0.11. At the moment, the stock has a 52-week-high of $33.20 and a 52-week-low of $23.25. Endeavor Group Holdings closed at $29.97 at the end of the last trading period.
  • JP Morgan initiated coverage on Aveanna Healthcare Holdings Inc AVAH with a Neutral rating. The price target for Aveanna Healthcare Hldgs is set to $14.00. The current stock performance of Aveanna Healthcare Hldgs shows a 52-week-high of $12.18 and a 52-week-low of $9.80. Moreover, at the end of the last trading period, the closing price was at $11.76.
  • Northland Capital Markets initiated coverage on Protagonist Therapeutics Inc PTGX with an Outperform rating. The price target for Protagonist Therapeutics is set to $42.00. In the first quarter, Protagonist Therapeutics showed an EPS of $0.54, compared to $0.72 from the year-ago quarter. The stock has a 52-week-high of $35.12 and a 52-week-low of $14.16. At the end of the last trading period, Protagonist Therapeutics closed at $34.28.
  • With a Buy rating, Jefferies initiated coverage on Aveanna Healthcare Holdings Inc AVAH. The price target seems to have been set at $15.00 for Aveanna Healthcare Hldgs. The current stock performance of Aveanna Healthcare Hldgs shows a 52-week-high of $12.18 and a 52-week-low of $9.80. Moreover, at the end of the last trading period, the closing price was at $11.76.
  • Jefferies initiated coverage on Endeavor Group Holdings Inc EDR with a Buy rating. The price target for Endeavor Group Holdings is set to $40.00. In the first quarter, Endeavor Group Holdings showed an EPS of $0.07, compared to $0.11 from the year-ago quarter. The current stock performance of Endeavor Group Holdings shows a 52-week-high of $33.20 and a 52-week-low of $23.25. Moreover, at the end of the last trading period, the closing price was at $29.97.
  • With a Buy rating, Craig-Hallum initiated coverage on Jamf Holding Corp JAMF. The price target seems to have been set at $43.00 for Jamf Holding. In the first quarter, Jamf Holding showed an EPS of $0.08, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $42.87 and a 52-week-low of $27.77. At the end of the last trading period, Jamf Holding closed at $30.38.
  • UBS initiated coverage on Endeavor Group Holdings Inc EDR with a Neutral rating. The price target for Endeavor Group Holdings is set to $33.00. For the first quarter, Endeavor Group Holdings had an EPS of $0.07, compared to year-ago quarter EPS of $0.11. The stock has a 52-week-high of $33.20 and a 52-week-low of $23.25. At the end of the last trading period, Endeavor Group Holdings closed at $29.97.
  • Raymond James initiated coverage on Aveanna Healthcare Holdings Inc AVAH with a Strong Buy rating. The price target for Aveanna Healthcare Hldgs is set to $15.00. The stock has a 52-week-high of $12.18 and a 52-week-low of $9.80. At the end of the last trading period, Aveanna Healthcare Hldgs closed at $11.76.
  • Deutsche Bank initiated coverage on Aveanna Healthcare Holdings Inc AVAH with a Buy rating. The price target for Aveanna Healthcare Hldgs is set to $13.50. The current stock performance of Aveanna Healthcare Hldgs shows a 52-week-high of $12.18 and a 52-week-low of $9.80. Moreover, at the end of the last trading period, the closing price was at $11.76.
  • With a Buy rating, Deutsche Bank initiated coverage on Endeavor Group Holdings Inc EDR. The price target seems to have been set at $33.00 for Endeavor Group Holdings. In the first quarter, Endeavor Group Holdings showed an EPS of $0.07, compared to $0.11 from the year-ago quarter. The current stock performance of Endeavor Group Holdings shows a 52-week-high of $33.20 and a 52-week-low of $23.25. Moreover, at the end of the last trading period, the closing price was at $29.97.
  • With an Outperform rating, Credit Suisse initiated coverage on FTC Solar Inc FTCI. The price target seems to have been set at $23.00 for FTC Solar. At the moment, the stock has a 52-week-high of $15.46 and a 52-week-low of $7.79. FTC Solar closed at $8.62 at the end of the last trading period.
  • With a Buy rating, Goldman Sachs initiated coverage on Coinbase Global Inc COIN. The price target seems to have been set at $306.00 for Coinbase Global. Coinbase Global earned $3.05 in the first quarter. The current stock performance of Coinbase Global shows a 52-week-high of $429.54 and a 52-week-low of $208.00. Moreover, at the end of the last trading period, the closing price was at $224.35.
  • With a Buy rating, Goldman Sachs initiated coverage on Reata Pharmaceuticals Inc RETA. The price target seems to have been set at $236.00 for Reata Pharmaceuticals. For the first quarter, Reata Pharmaceuticals had an EPS of $1.16, compared to year-ago quarter EPS of $1.47. The current stock performance of Reata Pharmaceuticals shows a 52-week-high of $186.82 and a 52-week-low of $76.34. Moreover, at the end of the last trading period, the closing price was at $110.98.
  • With an Overweight rating, Piper Sandler initiated coverage on Endeavor Group Holdings Inc EDR. The price target seems to have been set at $35.00 for Endeavor Group Holdings. In the first quarter, Endeavor Group Holdings showed an EPS of $0.07, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $33.20 and a 52-week-low of $23.25. Endeavor Group Holdings closed at $29.97 at the end of the last trading period.
  • With a Buy rating, Goldman Sachs initiated coverage on Stem Inc STEM. The price target seems to have been set at $30.00 for Stem. For the first quarter, Stem had an EPS of $1.32, compared to year-ago quarter EPS of $2.97. At the moment, the stock has a 52-week-high of $28.18 and a 52-week-low of $16.00. Stem closed at $22.09 at the end of the last trading period.
  • With a Equal-Weight rating, Wells Fargo initiated coverage on Tesla Inc TSLA. The price target seems to have been set at $590.00 for Tesla. In the first quarter, Tesla showed an EPS of $0.93, compared to $0.23 from the year-ago quarter. The current stock performance of Tesla shows a 52-week-high of $900.40 and a 52-week-low of $157.00. Moreover, at the end of the last trading period, the closing price was at $580.88.
  • BTIG initiated coverage on Omnicell Inc OMCL with a Buy rating. The price target for Omnicell is set to $165.00. In the first quarter, Omnicell showed an EPS of $0.83, compared to $0.66 from the year-ago quarter. The current stock performance of Omnicell shows a 52-week-high of $146.99 and a 52-week-low of $62.24. Moreover, at the end of the last trading period, the closing price was at $135.79.
  • With a Buy rating, HC Wainwright & Co. initiated coverage on GT Biopharma Inc GTBP. The price target seems to have been set at $25.00 for GT Biopharma. In the first quarter, GT Biopharma earned $1.83. The current stock performance of GT Biopharma shows a 52-week-high of $17.48 and a 52-week-low of $0.12. Moreover, at the end of the last trading period, the closing price was at $14.36.
  • With a Buy rating, HC Wainwright & Co. initiated coverage on Vaccitech PLC VACC. The price target seems to have been set at $25.00 for Vaccitech. The current stock performance of Vaccitech shows a 52-week-high of $17.99 and a 52-week-low of $12.25. Moreover, at the end of the last trading period, the closing price was at $14.58.
  • With an Outperform rating, SVB Leerink initiated coverage on Treace Medical Concepts Inc TMCI. The price target seems to have been set at $38.00 for Treace Medical Concepts. The stock has a 52-week-high of $34.47 and a 52-week-low of $24.25. At the end of the last trading period, Treace Medical Concepts closed at $28.77.

See all analyst ratings initiations.

Posted In: BZI-RatingsUpgradesDowngradesInitiationIntraday UpdateAnalyst Ratings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.